International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8067977
Original Article
Histopathological Spectrum of Lower Gastrointestinal Tract Biopsies: Study from North India
 ,
 ,
 ,
Published
June 22, 2023
Abstract
Introduction: The disorders of gastrointestinal tract are responsible for a great deal of morbidity and mortality. Endoscopy in combination with biopsy plays an important role in the exact diagnosis of gastrointestinal tract disorders for further management. Objectives: The aim of the study was to highlight the utility of colonoscopy biopsies in diagnosis of conditions affecting the lower gastrointestinal tract ranging from inflammatory to neoplastic. Material and Method: This was a retrospective observational study done in the histopathology department of this medical college of North India over a 1 year period. This comprises a spectrum of a total of 65 cases of lower gastrointestinal tract lesion in form of colonoscopies biopsies. A detailed demographic and clinical details regarding imaging and other biochemical investigations documented from the departmental records. Hematoxylin and Eosin-stained endoscopic biopsies of adequate size and representative areas were studied retrospectively. Results: Chronic nonspecific colitis was the predominant non-neoplastic lesion seen among 43% cases. Adenocarcinoma was the commonest malignant lesion contributing for 80 % of malignant lesions of lower GIT. Conclusion: The incidence of the non-neoplastic lesion is higher than the neoplastic lesion. The most common non-neoplastic lesion is chronic colitis. GIT endoscopy along with biopsy is an established procedure for investigating a wide range of gastrointestinal conditions.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
278 Views
286 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved